Soleus Capital Management, L.P. Surmodics Inc Transaction History
Soleus Capital Management, L.P.
- $1.22 Billion
- Q1 2024
A detailed history of Soleus Capital Management, L.P. transactions in Surmodics Inc stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 800,820 shares of SRDX stock, worth $33.7 Million. This represents 1.92% of its overall portfolio holdings.
Number of Shares
800,820
Previous 771,700
3.77%
Holding current value
$33.7 Million
Previous $28.1 Million
16.24%
% of portfolio
1.92%
Previous 3.62%
Shares
16 transactions
Others Institutions Holding SRDX
# of Institutions
111Shares Held
12.6MCall Options Held
200Put Options Held
4.7K-
Trigran Investments, Inc.2.36MShares$99.1 Million6.71% of portfolio
-
Black Rock Inc. New York, NY1.05MShares$44.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA865KShares$36.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY854KShares$35.9 Million0.0% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN659KShares$27.7 Million0.36% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $589M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...